A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
Clinical trial NCT03356158 · UNKNOWN
Trial details
- NCT number
- NCT03356158
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-15
- Primary completion
- 2018-10-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.